By identifying a specific set of inflammatory proteins that drive JMML's growth and weaken the immune system, IU researchers have uncovered a new strategy to combat the aggressive childhood blood cancer.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.